Back to Authors

Anand, Jasmeet

Mayo Clinic

Bristol-Myers Squibb (United States)

Citations 3

P915: TREATMENT PATTERNS AND CLINICAL OUTCOMES OF PATIENTS WITH MULTIPLE MYELOMA PREVIOUSLY TREATED WITH LENALIDOMIDE AND AN ANTI-CD38 MONOCLONAL ANTIBODY: FINDINGS FROM THE CONNECT MM DISEASE REGISTRY
Abonour, Rafat , Rifkin, Robert M. , Gasparetto, Christina, Durie, Brian G.M. , Terebelo, Howard R. , Narang, Mohit , Toomey, Kathleen, Tang, Yuexin , Dhanasiri, Sujith, Anand, Jasmeet, Yu, Edward, Marshall, Thomas, Liu, Liang , Ailawadhi, Sikander , Lee, Hans C. , Wagner, Lynne I. , Hardin, James W. , Jagannath, Sundar

HemaSphere | August 9, 2023 | Volume: 7 | Issue: S3 | Pages: e52503e2

10.1097/01.hs9.0000970564.52503.e2 Get It

Impact of COVID-19 on Treatment Patterns and Management of Multiple Myeloma: Insights from the Connect® MM Registry
Terebelo, Howard R. , Abonour, Rafat , Durie, Brian G.M. , Omel, James L., Narang, Mohit , Toomey, Kathleen, Rifkin, Robert M. , Gasparetto, Cristina, Yu, Edward, Anand, Jasmeet, Liu, Liang , Jou, Ying‐Ming, Jagannath, Sundar, Richter, Joshua , Ailawadhi, Sikander , Lee, Hans C. , Hardin, James W. , Wagner, Lynne I. , Omel, James, Gasparetto, Cristina , Jagannath, Sundar

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 8089-8091

10.1182/blood-2022-158627 Get It

Outcomes of Second-Line (2L) Triplet+ Regimens in Patients with Relapsed/Refractory Multiple Myeloma (MM) Following Progression after First-Line (1L) Lenalidomide in the Connect® MM Disease Registry
Abonour, Rafat , Durie, Brian G.M. , Gasparetto, Cristina, Narang, Mohit , Omel, James, Rifkin, Robert M. , Terebelo, Howard R. , Toomey, Kathleen, Slaff, Samantha, Danforth, Dailan, Chung, Weiyuan, Anand, Jasmeet, Yu, Edward, Tang, Derek, Jagannath, Sundar, Lee, Hans C. , Ailawadhi, Sikander , Gasparetto, Cristina , Hardin, James W. , Wagner, Lynne I. , Jagannath, Sundar

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 13256-13258

10.1182/blood-2022-158197 Get It